Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald L Yee

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Pediatrics|September 11, 2012
Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparinAshley A Richard, Shelly Kim, Brady S Moffett, et al.
The Annals of Pharmacotherapy|October 27, 2015
Use of 4-Factor Prothrombin Concentrate (Kcentra) in Hospitalized Pediatric PatientsRachel S Beaty, Brady S Moffett, Donald H Mahoney, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|April 26, 2019
A Critical Evaluation of Enoxaparin Dose Adjustment Guidelines in ChildrenChristine Nguyen Dinh, Brady S Moffett, Marianne Galati, et al.
International Journal of General Medicine|April 25, 2017
Recognition and management of platelet-refractory bleeding in patients with Glanzmann's thrombasthenia and other severe platelet function disordersMeera Chitlur, Madhvi Rajpurkar, Michael Recht, et al.
Journal of Pediatric Hematology/Oncology|January 7, 2017
Pediatric Acquired von Willebrand Syndrome in Cardiopulmonary Disorders: Do Laboratory Abnormalities Predict Bleeding Risk?Saman K Hashmi, Mireya P Velasquez, Donald L Yee, et al.
Pediatric Blood & Cancer|June 23, 2009
Varied opinions on thrombolysis for venous thromboembolism in infants and children: findings from a survey of pediatric hematology-oncology specialistsDonald L Yee, Anthony K C Chan, Suzan Williams, et al.
Therapeutic Drug Monitoring|September 23, 2017
Enoxaparin Population Pharmacokinetics in the First Year of LifeBrady S Moffett, Marianne Galati, Donald Mahoney, et al.
Archives of Pathology & Laboratory Medicine|July 29, 2005
A practical approach to pediatric patients referred with an abnormal coagulation profileMonica Acosta, Rachel Edwards, Ian M Jaffee, et al.
Pediatric Blood & Cancer|April 4, 2009
Ornithine transcarbamylase deficiency: a possible risk factor for thrombosisLakshmi Venkateswaran, Fernando Scaglia, Valerie McLin, et al.
Pediatric Blood & Cancer|November 14, 2008
Acquired von Willebrand syndrome and Wilms tumor: not always benignPatricia A Baxter, Jed G Nuchtern, Robert P Guillerman, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Pediatrics|September 11, 2012
Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparinAshley A Richard, Shelly Kim, Brady S Moffett, et al.
The Annals of Pharmacotherapy|October 27, 2015
Use of 4-Factor Prothrombin Concentrate (Kcentra) in Hospitalized Pediatric PatientsRachel S Beaty, Brady S Moffett, Donald H Mahoney, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|April 26, 2019
A Critical Evaluation of Enoxaparin Dose Adjustment Guidelines in ChildrenChristine Nguyen Dinh, Brady S Moffett, Marianne Galati, et al.
International Journal of General Medicine|April 25, 2017
Recognition and management of platelet-refractory bleeding in patients with Glanzmann's thrombasthenia and other severe platelet function disordersMeera Chitlur, Madhvi Rajpurkar, Michael Recht, et al.
Journal of Pediatric Hematology/Oncology|January 7, 2017
Pediatric Acquired von Willebrand Syndrome in Cardiopulmonary Disorders: Do Laboratory Abnormalities Predict Bleeding Risk?Saman K Hashmi, Mireya P Velasquez, Donald L Yee, et al.
Pediatric Blood & Cancer|June 23, 2009
Varied opinions on thrombolysis for venous thromboembolism in infants and children: findings from a survey of pediatric hematology-oncology specialistsDonald L Yee, Anthony K C Chan, Suzan Williams, et al.
Therapeutic Drug Monitoring|September 23, 2017
Enoxaparin Population Pharmacokinetics in the First Year of LifeBrady S Moffett, Marianne Galati, Donald Mahoney, et al.
Archives of Pathology & Laboratory Medicine|July 29, 2005
A practical approach to pediatric patients referred with an abnormal coagulation profileMonica Acosta, Rachel Edwards, Ian M Jaffee, et al.
Pediatric Blood & Cancer|April 4, 2009
Ornithine transcarbamylase deficiency: a possible risk factor for thrombosisLakshmi Venkateswaran, Fernando Scaglia, Valerie McLin, et al.
Pediatric Blood & Cancer|November 14, 2008
Acquired von Willebrand syndrome and Wilms tumor: not always benignPatricia A Baxter, Jed G Nuchtern, Robert P Guillerman, et al.
Pageof 5